Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) EBITDA (2020 - 2025)

Historic EBITDA for Aveanna Healthcare Holdings (AVAH) over the last 6 years, with Q3 2025 value amounting to $53.6 million.

  • Aveanna Healthcare Holdings' EBITDA rose 5748.59% to $53.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.2 million, marking a year-over-year increase of 8748.75%. This contributed to the annual value of $149.4 million for FY2024, which is 65174.62% up from last year.
  • Per Aveanna Healthcare Holdings' latest filing, its EBITDA stood at $53.6 million for Q3 2025, which was up 5748.59% from $80.0 million recorded in Q2 2025.
  • Aveanna Healthcare Holdings' 5-year EBITDA high stood at $80.0 million for Q2 2025, and its period low was -$456.4 million during Q3 2022.
  • Moreover, its 5-year median value for EBITDA was $28.3 million (2021), whereas its average is -$13.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 15830.59% in 2021, then crashed by 169498.64% in 2023.
  • Over the past 5 years, Aveanna Healthcare Holdings' EBITDA (Quarter) stood at $18.3 million in 2021, then plummeted by 1214.39% to -$204.5 million in 2022, then skyrocketed by 114.33% to $29.3 million in 2023, then surged by 56.25% to $45.8 million in 2024, then grew by 17.07% to $53.6 million in 2025.
  • Its EBITDA stands at $53.6 million for Q3 2025, versus $80.0 million for Q2 2025 and $51.8 million for Q1 2025.